Análisis Argos
HRB
HRBOportunidad
H&R Block, Inc. · Consumer Cyclical
US$ 44.94
precio al 2026-07-28
Valor justo Argos*
US$ 69–85
vs. su valor justo
41% por debajo
Score Argos
79/100
Oportunidad
LA RESPUESTA
El mercado la precia para que se encoja 11% al año — menos de lo que viene demostrando (8.7%). Un negocio de calidad castigado por expectativas pesimistas: por eso está entre las llamadas de Argos.
Recompensas
Cotiza por debajo de su valor justo: el mercado le pide menos crecimiento del que viene demostrando.
Retorno sobre el capital alto (45%).
Reparte dividendo sostenible (3.74%).
Riesgos
!Venta significativa de insiders en el último trimestre.
!Crecimiento estancado o en baja.
VALOR6/6FUTURO2/6PASADO5/6SALUD3/6DIVIDENDO6/6
El Iris de calidad
VALOR6/6FUTURO2/6PASADO5/6SALUD3/6DIVIDENDO6/6
ValorCotiza por debajo de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos79de 100Oportunidad
Ingresos4%
US$ 3.8 B
Margen operativo1%
22%
Flujo de caja libre9%
US$ 0.6 B
Deuda neta
US$ 1.3 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 5.7B
P/E9.4x
EV/EBITDA7.5x
FCF yield10.5%
ROIC45%
Margen operativo22%
Crecim. ingresos+4.2%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

globenewswire.com · 28 jul
H&R Block to Release Fiscal 2026 Results on August 11, 2026
KANSAS CITY, Mo., July 28, 2026 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) will report fourth quarter and fiscal 2026 full year results on Tuesday, August 11, 2026, after the New York Stock Exchange market close. At that time, a copy of the press release and presentation will be available on the company's investor relations website at https://investors.hrblock.com/.
247wallst.com · 28 jul
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today.
defenseworld.net · 26 jul
H&R Block, Inc. $HRB Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System reduced its holdings in shares of H&R Block, Inc. (NYSE: HRB) by 16.0% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 296,419 shares of the company's stock after selling 56,662 shares during the quarter. California
zacks.com · 8 jul
Here's Why H&R Block (HRB) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com · 6 jul
Best Growth Stocks to Buy for July 6th
PBI, ALH and HRB made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 6, 2026.
seekingalpha.com · 5 jul
H&R Block: Solid Rock And Trading At A Discount
H&R Block delivered a strong quarter with 6% EBITDA growth and 5.3% revenue growth, defying AI disruption fears. HRB's assisted tax segment had its best performance in 3 years. Overall volume decline was primarily free filers; paid filers declined less than 1%. Expense management and potential divestiture of underperforming units like Wave, Block Advisors, and Spruce could further enhance HRB's outlook.
247wallst.com · 26 jun
The Greenblatt Magic Formula: How H&R Block, Molina, and Peabody Stack Up for Retirement Investors
Joel Greenblatt's Magic Formula ranks stocks on two factors: earnings yield (EBIT divided by enterprise value) and return on capital.
zacks.com · 26 jun
Best Growth Stocks to Buy for June 26th
LYB, HRB and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26th, 2026.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.